Showing results (591-600 of 3,318) with videos related to
Sort By:
Pageof 332
Journal of Clinical Psychopharmacology|January 15, 2009
Mortality rates among patients with schizophrenia and tardive dyskinesiaSiow-Ann Chong, Jenny A M Tay, Mythily Subramaniam, et al.Journal of Clinical Psychopharmacology|January 15, 2009
Psychotropic drugs associated with corrected QT interval prolongationCharlotte van Noord, Sabine M J M Straus, Miriam C J M Sturkenboom, et al.Journal of Clinical Psychopharmacology|January 15, 2009
Association between HTR2C and HTR2A polymorphisms and metabolic abnormalities in patients treated with olanzapine or clozapineArzu Gunes, Kristina I Melkersson, Maria Gabriella Scordo, et al.Journal of Clinical Psychopharmacology|February 1, 1985
Adverse reactions to monoamine oxidase inhibitors. Part II. Treatment correlates and clinical managementJ G Rabkin, F M Quitkin, P McGrath, et al.Journal of Clinical Psychopharmacology|February 1, 1985
Alprazolam in the treatment of obsessive symptomsG TollefsonJournal of Clinical Psychopharmacology|October 1, 1986
Norepinephrine challenges in panic patientsR E Pyke, H S GreenbergJournal of Clinical Psychopharmacology|June 1, 1985
Serum neuroleptic levels and clinical outcome in schizophrenic patients treated with fluphenazine decanoateW A Brown, M A SilverJournal of Clinical Psychopharmacology|January 12, 2022
Comparative Efficacy and Tolerability of Antipsychotics for Juvenile Psychotic Disorders: A Systematic Review and Network Meta-AnalysisCaitlin S Yee, Anees Bahji, Maria Lolich, et al.Journal of Clinical Psychopharmacology|June 1, 1994
Nefazodone in the treatment of premenstrual syndrome: a preliminary studyE W Freeman, K Rickels, S J Sondheimer, et al.Journal of Clinical Psychopharmacology|December 1, 1993
A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trialN R Cutler, J J Sramek, J M Keppel Hesselink, et al.Pageof 332